학술논문
Efficacy and safety of tocilizumab in Japanese patients with systemic sclerosis and associated interstitial lung disease: A subgroup analysis of a global, randomised, controlled Phase 3 trial
Document Type
Article
Source
In: Modern Rheumatology . (Modern Rheumatology, 1 May 2024, 34(3):530-540)
Subject
Language
English
ISSN
14397609
14397595
14397595